Today, CMS released a fact sheet that gives more details on how a registry will work to make sure coverage will be available for any Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease that receives FDA traditional approval. Learn more: https://www.cms.gov/files/document/fact-sheet-june-2023.pdf |
Centers for Medicare & Medicaid Services (CMS) has sent this update. To contact Centers for Medicare & Medicaid Services (CMS) go to our contact us page. |
|